These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32805634)

  • 21. Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Oliva M; Huang SH; Xu W; Su J; Hansen AR; Bratman SV; Ringash J; Jang R; Cho J; Bayley A; Hope AJ; Chen E; Giuliani M; Waldron J; Weinreb I; Perez-Ordonez B; Chepeha D; Kim J; O Sullivan B; Siu LL; Spreafico A
    Eur J Cancer; 2019 Sep; 118():112-120. PubMed ID: 31330486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
    Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
    Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
    Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
    Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality-of-life scores compared to objective measures of swallowing after oropharyngeal chemoradiation.
    Kendall KA; Kosek SR; Tanner K
    Laryngoscope; 2014 Mar; 124(3):682-7. PubMed ID: 23929736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Predictors of Cisplatin Chemoradiation-Induced Ototoxicity in HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study.
    Lee JJ; Alamleh S; Zhan LJ; Hueniken K; Mahler MB; Billfalk-Kelly A; Davies J; Brown MC; Spreafico A; Huang SH; Hope A; Xu W; Goldstein DP; Liu G
    J Otolaryngol Head Neck Surg; 2024; 53():19160216241248671. PubMed ID: 39056507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes.
    Hunter KU; Schipper M; Feng FY; Lyden T; Haxer M; Murdoch-Kinch CA; Cornwall B; Lee CS; Chepeha DB; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):935-40. PubMed ID: 23040224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trial.
    Misiukiewicz K; Gupta V; Miles BA; Bakst R; Genden E; Selkridge I; Surgeon JT; Rainey H; Camille N; Roy E; Zhang D; Ye F; Jia R; Moshier E; Bonomi M; Hwang M; Som P; Posner MR
    Oral Oncol; 2019 Aug; 95():170-177. PubMed ID: 31345387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short- and long-term outcomes of oropharyngeal cancer care in the elderly.
    Motz K; Herbert RJ; Fakhry C; Quon H; Kang H; Kiess AP; Eisele DW; Koch WM; Frick KD; Gourin CG
    Laryngoscope; 2018 Sep; 128(9):2084-2093. PubMed ID: 29573418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Volumetric changes in pharyngeal structures following head and neck cancer chemoradiation therapy.
    Hinther A; Samson N; Lau H; Quon H; Banerjee R; Lysack JT; Grendarova P; Matthews TW; Randall DR
    Laryngoscope; 2020 Mar; 130(3):597-602. PubMed ID: 31260128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in Patient-reported Swallow Function in the Long Term After Chemoradiotherapy for Oropharyngeal Carcinoma.
    Martin A; Murray L; Sethugavalar B; Buchan C; Williams GF; Sen M; Prestwich RJD
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):756-763. PubMed ID: 30025978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx.
    Waddle MR; Ma DJ; Visscher SL; Borah BJ; May JM; Price KA; Moore EJ; Patel SH; Hinni ML; Chintakuntlawar AV; Garcia JJ; Graner DE; Neben-Wittich MA; Garces YI; Hallemeier CL; Price DL; Kasperbauer JL; Janus JR; Foote RL; Miller RC
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):396-402. PubMed ID: 33359567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrostomy Utilization by Oropharyngeal Cancer Patients Is Partially Driven by Swallowing Function.
    Chhabria K; Kansara S; Badr H; Stach C; Vernese M; Lerner A; Harms A; Hernandez DJ; Huang AT; Chen G; Parke RB; Charnitsky S; Sandulache VC
    Laryngoscope; 2020 Sep; 130(9):2153-2159. PubMed ID: 31566749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal Evaluation of Swallowing with Videofluoroscopy in Patients with Locally Advanced Head and Neck Cancer After Chemoradiation.
    Xinou E; Chryssogonidis I; Kalogera-Fountzila A; Panagiotopoulou-Mpoukla D; Printza A
    Dysphagia; 2018 Oct; 33(5):691-706. PubMed ID: 29572573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).
    Yom SS; Torres-Saavedra P; Caudell JJ; Waldron JN; Gillison ML; Xia P; Truong MT; Kong C; Jordan R; Subramaniam RM; Yao M; Chung CH; Geiger JL; Chan JW; O'Sullivan B; Blakaj DM; Mell LK; Thorstad WL; Jones CU; Banerjee RN; Lominska C; Le QT
    J Clin Oncol; 2021 Mar; 39(9):956-965. PubMed ID: 33507809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction chemotherapy followed by concurrent chemoradiation versus concurrent chemoradiation alone in the definitive management of p16-positive oropharyngeal squamous cell carcinoma with low-neck or N3 disease.
    Bhattasali O; Han J; Thompson LDR; Buchschacher GL; Abdalla IA; Iganej S
    Oral Oncol; 2018 Mar; 78():151-155. PubMed ID: 29496043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
    Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
    Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
    Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating predictive factors for toxicities experienced by head & neck cancer patients undergoing radiotherapy.
    Ray X; Sumner W; Sutton L; Sanghvi P; Deichaite I; Moiseenko V
    J Transl Med; 2021 Sep; 19(1):380. PubMed ID: 34493300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictable swallowing function after open horizontal supraglottic partial laryngectomy.
    Breunig C; Benter P; Seidl RO; Coordes A
    Auris Nasus Larynx; 2016 Dec; 43(6):658-65. PubMed ID: 26853312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.